Pembrolizumab Approved to Treat Metastatic Small Cell Lung Cancer - Pulmonology Advisor
Pembrolizumab Approved to Treat Metastatic Small Cell Lung Cancer Pulmonology Advisor
The Food and Drug Administration (FDA) has approved Keytruda (pembrolizumab; Merck) for the treatment of patients with metastatic small cell lung cancer ...
Comments
Post a Comment